Lochowicz AJ, Curtis BR. Clinical applications of platelet antibody and antigen testing. Lab Med 2011;42:687–92.LochowiczAJCurtisBR.Clinical applications of platelet antibody and antigen testing. Lab Med2011;42:687–92.10.1309/LMM242GKGHCKJRWISearch in Google Scholar
Ikeda H, Mitani T, Ohnuma M, et al. A new PLT-specific antigen, Naka, involved in the refractoriness of HLA-matched PLT transfusion. Vox Sang 1989;57:213–7.IkedaHMitaniTOhnumaM, A new PLT-specific antigen, Naka, involved in the refractoriness of HLA-matched PLT transfusion. Vox Sang1989;57:213–7.10.1111/j.1423-0410.1989.tb00826.x2617957Search in Google Scholar
Curtis BR, Aster RH. Incidence of the Naka-negative PLT phenotype in African Americans is similar to that of Asians. Transfusion 1996;36:331–4.CurtisBRAsterRH.Incidence of the Naka-negative PLT phenotype in African Americans is similar to that of Asians. Transfusion1996;36:331–4.10.1046/j.1537-2995.1996.36496226147.x8623134Search in Google Scholar
Lee K, Godeau B, Fromont P, et al. CD36 deficiency is frequent and can cause PLT immunization in Africans. Transfusion 1999;39:873–9.LeeKGodeauBFromontP, CD36 deficiency is frequent and can cause PLT immunization in Africans. Transfusion1999;39:873–9.10.1046/j.1537-2995.1999.39080873.x10504124Search in Google Scholar
Yanai H, Chiba H, Fujiwara H, et al. Phenotype-genotype correlation in CD36 deficiency types I and II. Thromb Haemost 2000;84:436–41.YanaiHChibaHFujiwaraH, Phenotype-genotype correlation in CD36 deficiency types I and II. Thromb Haemost2000;84:436–41.10.1055/s-0037-1614041Search in Google Scholar
Li R, Qiao Z, Ling B, Lu P, Zhu Z. Incidence and molecular basis of CD36 deficiency in Shanghai population. Transfusion 2015;55:666–73.LiRQiaoZLingBLuPZhuZ.Incidence and molecular basis of CD36 deficiency in Shanghai population. Transfusion2015;55:666–73.10.1111/trf.1289025330908Search in Google Scholar
Metzner K, Bauer J, Ponzi H, Ujcich A, Curtis BR. Detection and identification of PLT antibodies using a sensitive multiplex assay system: PLT antibody bead array (PABA). Transfusion 2017;57:1724–33.MetznerKBauerJPonziHUjcichACurtisBR.Detection and identification of PLT antibodies using a sensitive multiplex assay system: PLT antibody bead array (PABA). Transfusion2017;57:1724–33.10.1111/trf.1412228439930Search in Google Scholar
Yamamoto N, Ikeda H, Tandon NN, et al. A PLT membraneglycoprotein (GP) deficiency in healthy blood donors: Naka-PLTs lack detectable GPIV (CD36). Blood 1990;76:1698–703.YamamotoNIkedaHTandonNN, A PLT membraneglycoprotein (GP) deficiency in healthy blood donors: Naka-PLTs lack detectable GPIV (CD36). Blood1990;76:1698–703.10.1182/blood.V76.9.1698.1698Search in Google Scholar
Curtis BR, Ali S, Glazier AM, Ebert DD, Aitman TJ, Aster RH. Isoimmunization against CD36 (glycoprotein IV): description of four cases of neonatal isoimmune thrombocytopenia and brief review of the literature. Transfusion 2002;42:1173–9.CurtisBRAliSGlazierAMEbertDDAitmanTJAsterRH.Isoimmunization against CD36 (glycoprotein IV): description of four cases of neonatal isoimmune thrombocytopenia and brief review of the literature. Transfusion2002;42:1173–9.10.1046/j.1537-2995.2002.00176.x12430674Search in Google Scholar
Okajima S, Cho K, Chiba H, et al. Two sibling cases of hydrops fetalis due to alloimmune anti-CD36 (Nak a) antibody. Thromb Haemost 2006;95:267–71.OkajimaSChoKChibaH, Two sibling cases of hydrops fetalis due to alloimmune anti-CD36 (Nak a) antibody. Thromb Haemost2006;95:267–71.10.1160/TH05-05-037816493488Search in Google Scholar
Chilongola J, Balthazary S, Mpina M, Mhando M, Mbugi E. CD36 deficiency protects against malarial anaemia in children by reducing Plasmodium falciparum-infected red blood cell adherence to vascular endothelium. Trop Med Int Health 2009;14:810–6.ChilongolaJBalthazarySMpinaMMhandoMMbugiE.CD36 deficiency protects against malarial anaemia in children by reducing Plasmodium falciparum-infected red blood cell adherence to vascular endothelium. Trop Med Int Health2009;14:810–6.10.1111/j.1365-3156.2009.02298.xSearch in Google Scholar
Hirano K, Kuwasako T, Nakagawa-Toyama Y, Janabi M, Yamashita S, Matsuzawa Y. Pathophysiology of human genetic CD36 deficiency. Trends Cardiovasc Med 2003;13:136–41.HiranoKKuwasakoTNakagawa-ToyamaYJanabiMYamashitaSMatsuzawaY.Pathophysiology of human genetic CD36 deficiency. Trends Cardiovasc Med2003;13:136–41.10.1016/S1050-1738(03)00026-4Search in Google Scholar
Furuhashi M, Ura N, Nakata T, Tanaka T, Shimamoto K. Genotype in human CD36 deficiency and diabetes mellitus. Diabet Med 2004;21:952–3.FuruhashiMUraNNakataTTanakaTShimamotoK.Genotype in human CD36 deficiency and diabetes mellitus. Diabet Med2004;21:952–3.10.1111/j.1464-5491.2004.01248.x15270806Search in Google Scholar
Love-Gregory L, Sherva R, Sun L, et al. Variants in the CD36 gene associate with the metabolic syndrome and high-density lipoprotein cholesterol. Hum Mol Genet 2008;17:1695–704.Love-GregoryLShervaRSunL, Variants in the CD36 gene associate with the metabolic syndrome and high-density lipoprotein cholesterol. Hum Mol Genet2008;17:1695–704.10.1093/hmg/ddn060265522818305138Search in Google Scholar
Saw CL, Szykoluk H, Curtis BR, et al. Two cases of PLT transfusion refractoriness associated with anti-CD36. Transfusion 2010;50:2638–42.SawCLSzykolukHCurtisBR, Two cases of PLT transfusion refractoriness associated with anti-CD36. Transfusion2010;50:2638–42.10.1111/j.1537-2995.2010.02749.x20561295Search in Google Scholar
Xia W, Ye X, Xu X, et al. Two cases of PLT transfusion refractoriness and one case of possible FNAIT caused by antibodies against CD36 in China. Transfus Med 2014;24: 254–6.XiaWYeXXuX, Two cases of PLT transfusion refractoriness and one case of possible FNAIT caused by antibodies against CD36 in China. Transfus Med2014;24: 254–6.10.1111/tme.1213725124074Search in Google Scholar
Xu X, Li L, Xia W, et al. Successful management of a hydropic fetus with severe anemia and thrombocytopenia caused by anti-CD36 antibody. Int J Hematol 2018;107:251–6.XuXLiLXiaW, Successful management of a hydropic fetus with severe anemia and thrombocytopenia caused by anti-CD36 antibody. Int J Hematol2018;107:251–6.10.1007/s12185-017-2310-528815406Search in Google Scholar
Galeotti C, Kaveri SV, Bayry J. IVIG-mediated effector functions in autoimmune and inflammatory diseases. Int Immunol 2017;29:491–8.GaleottiCKaveriSVBayryJ.IVIG-mediated effector functions in autoimmune and inflammatory diseases. Int Immunol2017;29:491–8.10.1093/intimm/dxx03928666326Search in Google Scholar
Maloney DG, Grillo-Lopez AJ, White CA, et al. IDEC-C2B8 (rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin’s lymphoma. Blood 1997;90:2188–95.MaloneyDGGrillo-LopezAJWhiteCA, IDEC-C2B8 (rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin’s lymphoma. Blood1997;90:2188–95.10.1182/blood.V90.6.2188Search in Google Scholar
Kneitz C, Wilhelm M, Tony HP. Effective B cell depletion with rituximab in the treatment of autoimmune diseases. Immunobiology 2002;206:519–27.KneitzCWilhelmMTonyHP.Effective B cell depletion with rituximab in the treatment of autoimmune diseases. Immunobiology2002;206:519–27.10.1078/0171-2985-0020012607727Search in Google Scholar
Egawa H, Teramukai S, Haga H, Tanabe T, Fukushima M, Shimazu M. Present status of ABO-incompatible living donor liver transplantation in Japan. Hepatology 2008;47143–52.EgawaHTeramukaiSHagaHTanabeTFukushimaMShimazuM.Present status of ABO-incompatible living donor liver transplantation in Japan. Hepatology2008;47143–52.10.1002/hep.2192817929298Search in Google Scholar
Cid J, Magnano L, Acosta M, Alba C, Esteve J, Lozano M. Rituximab, plasma exchange and intravenous immunoglobulins as a new treatment strategy for severe HLA alloimmune platelet refractoriness. Platelets 2015;26:190–4.CidJMagnanoLAcostaMAlbaCEsteveJLozanoM.Rituximab, plasma exchange and intravenous immunoglobulins as a new treatment strategy for severe HLA alloimmune platelet refractoriness. Platelets2015;26:190–4.10.3109/09537104.2014.89592224867634Search in Google Scholar
Kornor H, Hammerstrom KT, Brurberg KG, Klemp Gjertsen M, Froland S, Eds. Immunomodulatory treatments with intravenous immunoglobulin. Report from Norwegian Knowledge Centre for the Health Services (NOKC), no. 14–2008. NIPH systematic reviews: executive summaries. Oslo, Norway: Knowledge Centre for the Health Services, The Norwegian Institute of Public Health (NIPH); 2008.KornorHHammerstromKTBrurbergKGKlemp GjertsenMFrolandS, Eds. Immunomodulatory treatments with intravenous immunoglobulin. Report from Norwegian Knowledge Centre for the Health Services (NOKC), no. 14–2008. NIPH systematic reviews: executive summaries. Oslo, Norway: Knowledge Centre for the Health Services, The Norwegian Institute of Public Health (NIPH); 2008.Search in Google Scholar
Winkelhorst D, Oepkes D, Lopriore E. Fetal and neonatal alloimmune thrombocytopenia: evidence based antenatal and postnatal management strategies. Expert Rev Hematol 2017;10:729–37.WinkelhorstDOepkesDLoprioreE.Fetal and neonatal alloimmune thrombocytopenia: evidence based antenatal and postnatal management strategies. Expert Rev Hematol2017;10:729–37.10.1080/17474086.2017.134647128644735Search in Google Scholar
Taketani T, Ito K, Mishima S, et al. Neonatal isoimmune thrombocytopenia caused by type I CD36 deficiency having novel splicing isoforms of the CD36 gene. Eur J Haematol 2008;81:70–4.TaketaniTItoKMishimaS, Neonatal isoimmune thrombocytopenia caused by type I CD36 deficiency having novel splicing isoforms of the CD36 gene. Eur J Haematol2008;81:70–4.10.1111/j.1600-0609.2008.01093.x18462250Search in Google Scholar
Bierling P, Godeau B, Fromont P, et al. Posttransfusion purpura-like syndrome associated with CD36 (Naka) isoimmunization. Transfusion 1995;35:777–82.BierlingPGodeauBFromontP, Posttransfusion purpura-like syndrome associated with CD36 (Naka) isoimmunization. Transfusion1995;35:777–82.10.1046/j.1537-2995.1995.35996029165.x7570941Search in Google Scholar
